IDH Results Presentation

April 2023

Contents:

  • IDH At a Glance
  • FY 2022 Results Overview
  • Key Investment Highlights
    • Our Market
    • Our Business Model
    • Financial Position and Performance
    • Growth Strategies
    • Governance

Who We Are

Integrated Diagnostics Holding is a leading, fully-integrated provider of high-quality medical

diagnostic services with a footprint spanning Egypt, Jordan, Sudan and Nigeria

Our Services

Our Brands

Accreditations

Immunology Endocrinology Cytogenetics

Clinical

MicrobiologyHistopathology

Chemistry

Molecular

HaematologyRadiology

Biology

+ 40 years

Track record

+2,000

Diagnostic tests offered

7 key brands

With strong awareness

4

Country footprint (Egypt, Jordan, Sudan & Nigeria)

552

Branch labs as at 31 Dec. 2022

8.7 MN

FY22 Patients

32.7 MN

FY22 Tests

21%

Hena Holdings

Ltd

EGP 3.5BN

Shareholding 52%

Actis Idn B.V.

Structure

Free Float

FY22 Net Sales

27%

3 INTEGRATED DIAGNOSTICS HOLDINGS

Our Geography

IDH currently operates the largest branch network amongst private providers in Egypt and boasts

an established presence in four key markets in the Middle East and Africa

Egypt

1979

500

#1

First began

Branches (52% in

Market Ranking1

(#1 in Corporate

operations

Cairo Region)

Insurance Sector)

82%

7.6 mn

29.5 mn

Share of

Patients served

Tests performed

consolidated net

in 2022

in 2022

sales in FY 2022

Jordan

2011

23

#1

Acquisition of

Branches

Market Ranking1

Biolab

15%

890k

2.8 mn

Share of

Patients served

Tests performed

consolidated net

in 2022

in 2022

sales in FY 2022

1 Market ranking amongst private players in each respective country.

Nigeria

2018

12

2%

Acquisition of

Share of

Branches

consolidated net

Echo Lab

sales in FY 2022

149k

303k

Patients served

Tests performed

in 2022

in 2022

Sudan

2011

17

#1

First began

Branches

Market Ranking1

operations

1%

70k

139k

Share of

Patients served

Tests performed

consolidated net

in 2022

in 2022

sales in FY 2022

4 INTEGRATED DIAGNOSTICS HOLDINGS

Our Patients

IDH serves two principal types of patients: contract and walk-in

Around 70% of total revenue generated across the two segments is paid in cash

Contract Patients

Walk-In Patients

IDH's contract clients include institutions who enter into one-year renewable contracts at agreed rates per-testand on a per-clientbasis. Around 40% of the revenue generated by the segment is paid in cash. IDH's corporate clients roster currently features institutions such as:

  • Unions
  • Syndicates

IDH's walk-in clients, also referred to as "self-payers",pay out of pocket for diagnostic tests and other services.

  • Private and public insurance companies
  • Banks and corporations
  • Public institutions

Contribution to IDH Net Sales (FY 2022)

41% EGP

3,542

mn 59%

Patient Split by Segment (FY 2022)

30%

8.7 mn

patients

70%

Contract Revenues

Walk-in Revenues

Contract Patients

Walk-in Patients

5 INTEGRATED DIAGNOSTICS HOLDINGS

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

IDH - Integrated Diagnostics Holdings plc published this content on 19 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 April 2023 15:29:01 UTC.